{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-004562","form_type":"8-K","ticker":"HBIO","cik":"0001123494","company_name":"HARVARD BIOSCIENCE INC","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.228594+00:00","generated_at":"2026-05-31T10:41:17.615342+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Harvard Bioscience Q2 revenue $23.1M (-20% YoY); GAAP net loss $2.9M","bullets":["Q2 revenue $23.1M, down 20% from $28.8M; gross margin 57.2% vs 58.0%.","GAAP operating loss $2.1M vs income $0.8M; diluted GAAP EPS -$0.07 vs -$0.02.","Adjusted EBITDA $1.3M (5.5% margin) vs $3.9M (13.6%); adjusted EPS $0.00.","Q2 cash from operations $0.6M vs $5.4M; cost actions expected to save $4M annually.","CEO cites challenging market with recovery delayed to later in second half."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-004562","json":"https://secwatch.observer/filing/0001171843-24-004562.json","markdown":"https://secwatch.observer/filing/0001171843-24-004562.md","text":"https://secwatch.observer/filing/0001171843-24-004562.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1123494/000117184324004562/0001171843-24-004562-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1123494/000117184324004562/f8k_080824.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:41:17.615342+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}